2-(Di-1-adamantylphosphino)phenylpiperidine
|
K029074-1g
|
95% |
1237588-13-4 |
1g
|
¥ 2525.0
|
4~8周 |
科威 |
2-(Di-1-adamantylphosphino)phenylpiperidine
|
K029074-250mg
|
95% |
1237588-13-4 |
250mg
|
¥ 791.0
|
4~8周 |
科威 |
N-[2-(di-1-adamantylphosphino)phenyl]morpholine,98% Mor-DalPhos
|
K029073-250mg
|
97% |
1237588-12-3 |
250mg
|
¥ 1409.0
|
4~8周 |
科威 |
N-[2-(di-1-adamantylphosphino)phenyl]morpholine,98% Mor-DalPhos
|
K029073-1g
|
97% |
1237588-12-3 |
1g
|
¥ 4595.0
|
4~8周 |
科威 |
1-Benzyl-4-(N-phenylacetamido)piperidine
|
K029072-250mg
|
98% |
1237-52-1 |
250mg
|
¥ 1558.0
|
4~8周 |
科威 |
吡咯烷
|
K011717-100ml
|
99% |
123-75-1 |
100ml
|
¥ 73.0
|
现货 |
科威 |
吡咯烷
|
K011717-2.5L
|
99% |
123-75-1 |
2.5L
|
¥ 1184.0
|
5~7个工作日 |
科威 |
吡咯烷
|
K011717-500ml
|
99% |
123-75-1 |
500ml
|
¥ 294.0
|
现货 |
科威 |
(R)-(-)-4-硝基苯磺酸缩水甘油酯
|
K029071-1g
|
97% |
123750-60-7 |
1g
|
¥ 1934.0
|
现货 |
科威 |
(R)-(-)-4-硝基苯磺酸缩水甘油酯
|
K029071-5g
|
97% |
123750-60-7 |
5g
|
¥ 6436.0
|
现货 |
科威 |
(R)-(-)-4-硝基苯磺酸缩水甘油酯
|
K029071-250mg
|
97% |
123750-60-7 |
250mg
|
¥ 803.0
|
现货 |
科威 |
正丁醛
|
K014584-500ml
|
99.5% |
123-72-8 |
500ml
|
¥ 252.0
|
5~7个工作日 |
科威 |
正丁醛
|
K014584-100ml
|
99.5% |
123-72-8 |
100ml
|
¥ 87.0
|
现货 |
科威 |
正丁醛
|
K014583-100ml
|
AR,98% |
123-72-8 |
100ml
|
¥ 31.0
|
现货 |
科威 |
正丁醛
|
K014583-2.5L
|
AR,98% |
123-72-8 |
2.5L
|
¥ 342.0
|
现货 |
科威 |
正丁醛
|
K014583-500ml
|
AR,98% |
123-72-8 |
500ml
|
¥ 75.0
|
现货 |
科威 |
正丁醛
|
K014582-5ml
|
standard for GC,>99.5%(GC) |
123-72-8 |
5ml
|
¥ 61.0
|
现货 |
科威 |
己酸烯丙酯
|
K003254-500ml
|
98% |
123-68-2 |
500ml
|
¥ 338.0
|
现货 |
科威 |
己酸烯丙酯
|
K003254-100ml
|
98% |
123-68-2 |
100ml
|
¥ 97.0
|
现货 |
科威 |
Pimasertib (AS-703026)
|
K019193-50mg
|
98% |
1236699-92-5 |
50mg
|
¥ 3184.0
|
现货 |
科威 |
Pimasertib (AS-703026)
|
K019193-10mg
|
98% |
1236699-92-5 |
10mg
|
¥ 932.0
|
现货 |
科威 |
Pimasertib (AS-703026)
|
K019193-5mg
|
98% |
1236699-92-5 |
5mg
|
¥ 587.0
|
现货 |
科威 |
Iguratimod
|
K029070-5mg
|
98% |
123663-49-0 |
5mg
|
¥ 2062.0
|
4~8周 |
科威 |
Iguratimod
|
K029070-50mg
|
98% |
123663-49-0 |
50mg
|
¥ 13406.0
|
4~8周 |
科威 |